85 related articles for article (PubMed ID: 9470842)
1. Management and survival of ovarian cancer patients in south east England.
Wolfe CD; Tilling K; Raju KS
Eur J Cancer; 1997 Oct; 33(11):1835-40. PubMed ID: 9470842
[TBL] [Abstract][Full Text] [Related]
2. National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England.
Shaw M; Wolfe C; Raju KS; Papadopoulos A
Eur J Gynaecol Oncol; 2003; 24(3-4):246-50. PubMed ID: 12807233
[TBL] [Abstract][Full Text] [Related]
3. Variations in the screening history and appropriateness of management of cervical cancer in South East England.
Wolfe CD; Tilling K; Bourne HM; Raju KS
Eur J Cancer; 1996 Jun; 32A(7):1198-204. PubMed ID: 8758253
[TBL] [Abstract][Full Text] [Related]
4. Variations in the management and survival of women under 50 years with breast cancer in the South East Thames region.
Richards MA; Wolfe CD; Tilling K; Barton J; Bourne HM; Gregory WM
Br J Cancer; 1996 Mar; 73(6):751-7. PubMed ID: 8611375
[TBL] [Abstract][Full Text] [Related]
5. The management of women with apparent early ovarian cancer in the south-west region of England.
Olaitan A; Murdoch J; Weeks J; James J; Howe K
J Obstet Gynaecol; 2002 Jul; 22(4):394-8. PubMed ID: 12521463
[TBL] [Abstract][Full Text] [Related]
6. The surgical management of women with ovarian cancer in the south west of England.
Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
[TBL] [Abstract][Full Text] [Related]
7. Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996.
Olaitan A; Mocroft A; Jacobs I
BJOG; 2000 Sep; 107(9):1094-6. PubMed ID: 11002951
[TBL] [Abstract][Full Text] [Related]
8. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
9. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998.
Bailey J; Murdoch J; Anderson R; Weeks J; Foy C
Int J Gynecol Cancer; 2006; 16 Suppl 1():25-9. PubMed ID: 16515563
[TBL] [Abstract][Full Text] [Related]
10. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
11. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the incidence and mortality of vulval cancer in women in South East England 1960-1999.
Somoye GO; Mocroft A; Olaitan A
Arch Gynecol Obstet; 2009 Feb; 279(2):113-7. PubMed ID: 18488239
[TBL] [Abstract][Full Text] [Related]
13. Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.
Pollock AM; Benster R; Vickers N
J Public Health Med; 1995 Dec; 17(4):419-28. PubMed ID: 8639341
[TBL] [Abstract][Full Text] [Related]
14. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study.
Melamed A; Fink G; Wright AA; Keating NL; Gockley AA; Del Carmen MG; Schorge JO; Rauh-Hain JA
BMJ; 2018 Jan; 360():j5463. PubMed ID: 29298771
[TBL] [Abstract][Full Text] [Related]
15. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines.
Shylasree TS; Howells RE; Lim K; Jones PW; Fiander A; Adams M; Evans AS;
Int J Gynecol Cancer; 2006; 16(5):1770-6. PubMed ID: 17009970
[TBL] [Abstract][Full Text] [Related]
16. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
17. Non-surgical management of ovarian cancer: Prevalence and implications.
Shalowitz DI; Epstein AJ; Ko EM; Giuntoli RL
Gynecol Oncol; 2016 Jul; 142(1):30-37. PubMed ID: 27107721
[TBL] [Abstract][Full Text] [Related]
18. Multiple cancer site comparison of adjusted survival by hospital of treatment: an East Anglian study.
Stockton D; Davies T
Br J Cancer; 2000 Jan; 82(1):208-12. PubMed ID: 10638991
[TBL] [Abstract][Full Text] [Related]
19. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study.
Seagle BL; Graves S; Strohl AE; Shahabi S
Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362
[TBL] [Abstract][Full Text] [Related]
20. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
